Lyra Therapeutics Inc (LYRA NASDAQ) stock market data APIs
$6.3831
-0.01(-0.2%)
as of September 17, 2025
Try our APIs with
free plan!
Lyra Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix which is in Phase III clinical trial for the treatment of chronic rhinosinusitis (CRS); and LYR-220 for CRS patients who have failed previous medical management and continue to require treatment to manage CRS symptoms. It has a collaboration agreement with LianBio Inflammatory Limited to develop and commercialize LYR-210 in mainland China, Hong Kong, Taiwan, Macau, South Korea, Singapore, and Thailand. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018. Lyra Therapeutics, Inc. was incorporated in 2005 and is headquartered in Watertown, Massachusetts.
Prev. Close
6.3831
Open
6.3728
High
6.8746
Low
6.3728
52 wk Range
3.81-34
Market Cap
10 557 K
Shares Outstanding
1 644 K
Revenue
770 K
EPS
-5.2194
Beta
0.174
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Lyra Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Lyra Therapeutics Inc data using free add-ons & libraries
Get Lyra Therapeutics Inc Fundamental Data
Lyra Therapeutics Inc Fundamental data includes:
- Net Revenue: 770 K
- EBITDA: -35 343 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.165
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Lyra Therapeutics Inc News
New
Lyra Therapeutics GAAP EPS of -$5.51, revenue of $0.18M
* Lyra Therapeutics press release [https://seekingalpha.com/pr/20198552-lyra-therapeutics-reports-second-quarter-2025-financial-results-and-provides-corporate-update] (NASDAQ:LYRA [https://seekingal...
Lyra earnings missed by $5.34, revenue fell short of estimates
Investing.com - Lyra (NASDAQ: LYRA) reported second quarter EPS of $-5.510, $5.34 worse than the analyst estimate of $-0.170. Revenue for the quarter came in at $183K versus the consensus estimate of ...
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
– Positive ENLIGHTEN 2 Phase 3 results announced in June 2025 propel business activities in manufacturing, regulatory strategy and ENLIGHTEN clinical dataset analysis to advance path forward for LYR...
Lyra Therapeutics registers shares for resale from warrant exercises
* Lyra Therapeutics (NASDAQ:LYRA [https://seekingalpha.com/symbol/LYRA]) registers 846,744 shares of common stock for resale by selling securityholders. * Shares are issuable upon exercise of outs...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
